Suppr超能文献

统一多系统萎缩评定量表的项目反应理论分析。

An Item Response Theory analysis of the Unified Multiple System Atrophy Rating Scale.

机构信息

French Reference Centre for MSA, University Hospital Bordeaux, Bordeaux, France; Univ. Bordeaux, INSERM, BPH, U1219, F-33000 Bordeaux, France; Inserm, CIC 1401 Bordeaux, Clinical Epidemiology Unit, F-33000 Bordeaux, France; Institut des Maladies Neurodégénératives, CNRS, UMR 5293, Bordeaux University, Bordeaux, France.

French Reference Centre for MSA, University Hospital Toulouse, Toulouse, France; Institut des Maladies Métaboliques et Cardiovasculaires, Inserm U 1297, Toulouse University, Toulouse, France.

出版信息

Parkinsonism Relat Disord. 2022 Jan;94:40-44. doi: 10.1016/j.parkreldis.2021.11.024. Epub 2021 Nov 30.

Abstract

INTRODUCTION

The Unified Multiple System Atrophy Rating Scale (UMSARS) has four subscales that have been specifically designed for the clinical assessment of MSA patients. UMSARS I (activities of daily living) and II (motor examination) subscales are regularly used as primary endpoints in treatment trials. The main objective of this study was to identify UMSARS I and II subscale items that best describe progression over time.

METHODS

All MSA patients seen at the French Reference Centre for MSA from 2007 to 2020 were included in a prospective cohort with an annual follow-up assessment including UMSARS. The repeated measures of the 26 UMSARS I and II items were analyzed using a longitudinal Item Response Theory model to identify the most informative items for each of the five UMSARS IV disease stages. Sample size estimates were further calculated for the most informative items as a group.

RESULTS

A total of 557 MSA patients were included with a mean follow-up of 2.3 years. The majority of items progressed with disease duration or across the different UMSARS IV disability stages, with the exception of those related to dysautonomia. Roughly 70% of the scale information was carried by only 11/26 items, many reflecting the patient perspective. These yielded similar sample size estimates than UMSARS I + II items.

CONCLUSION

This study provides important information about the progression of UMSARS I and II subscale items. Improvements seem particularly necessary regarding those assessing dysautonomia. A shortened scale may be useful as outcome for future clinical trials.

摘要

简介

统一多系统萎缩评定量表(UMSARS)有四个亚量表,专为 MSA 患者的临床评估而设计。UMSARS I(日常生活活动)和 II(运动检查)亚量表通常作为治疗试验的主要终点。本研究的主要目的是确定 UMSARS I 和 II 亚量表项目,以最好地描述随时间的进展。

方法

从 2007 年到 2020 年,所有在法国 MSA 参考中心就诊的 MSA 患者均被纳入前瞻性队列研究,每年进行一次随访评估,包括 UMSARS。使用纵向项目反应理论模型分析 26 项 UMSARS I 和 II 项目的重复测量,以确定每个 UMSARS IV 疾病阶段最具信息量的项目。进一步计算了最具信息量的项目作为一个组的样本量估计。

结果

共纳入 557 例 MSA 患者,平均随访 2.3 年。大多数项目随着疾病持续时间或不同 UMSARS IV 残疾阶段而进展,自主神经功能障碍相关项目除外。大约 70%的量表信息仅由 11/26 个项目携带,其中许多反映了患者的观点。这些项目的样本量估计与 UMSARS I+II 项目相似。

结论

本研究提供了 UMSARS I 和 II 亚量表项目进展的重要信息。在评估自主神经功能障碍方面似乎特别需要改进。缩短的量表可能对未来的临床试验有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验